| pubmed-article:7627722 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7627722 | lifeskim:mentions | umls-concept:C1257890 | lld:lifeskim |
| pubmed-article:7627722 | lifeskim:mentions | umls-concept:C0546837 | lld:lifeskim |
| pubmed-article:7627722 | lifeskim:mentions | umls-concept:C0021083 | lld:lifeskim |
| pubmed-article:7627722 | lifeskim:mentions | umls-concept:C0596382 | lld:lifeskim |
| pubmed-article:7627722 | lifeskim:mentions | umls-concept:C0034656 | lld:lifeskim |
| pubmed-article:7627722 | lifeskim:mentions | umls-concept:C2603343 | lld:lifeskim |
| pubmed-article:7627722 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:7627722 | lifeskim:mentions | umls-concept:C2745888 | lld:lifeskim |
| pubmed-article:7627722 | lifeskim:mentions | umls-concept:C0681890 | lld:lifeskim |
| pubmed-article:7627722 | lifeskim:mentions | umls-concept:C0022341 | lld:lifeskim |
| pubmed-article:7627722 | lifeskim:mentions | umls-concept:C1514923 | lld:lifeskim |
| pubmed-article:7627722 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:7627722 | pubmed:dateCreated | 1995-9-7 | lld:pubmed |
| pubmed-article:7627722 | pubmed:abstractText | The aim of this report is to evaluate retrospectively the data from a prospective randomized study of 158 esophageal cancer patients who actually completed therapy with protein-bound polysaccharide P (PSK) and the 5-year survivals with and without raised alpha 1-antichymotrypsin and sialic acid levels to determine the value of these parameters in predicting effectiveness of immunotherapy. There was a significant difference in survival between the patients with and without PSK therapy. The survival of the radiochemotherapy plus PSK group treated for > 3 months was significantly better than that of the radiochemotherapy group. Among the patients with abnormal levels of alpha 1-antichymotrypsin and sialic acid, those who received PSK may have a significantly better survival than those without PSK. These results indicate that the preoperative serum levels of alpha 1-antichymotrypsin and sialic acid may possibly predict the effectiveness of immunotherapy using PSK. | lld:pubmed |
| pubmed-article:7627722 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7627722 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7627722 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7627722 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7627722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7627722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7627722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7627722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7627722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7627722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7627722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7627722 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7627722 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7627722 | pubmed:issn | 0735-7907 | lld:pubmed |
| pubmed-article:7627722 | pubmed:author | pubmed-author:EndohMM | lld:pubmed |
| pubmed-article:7627722 | pubmed:author | pubmed-author:IsonoKK | lld:pubmed |
| pubmed-article:7627722 | pubmed:author | pubmed-author:SugitaMM | lld:pubmed |
| pubmed-article:7627722 | pubmed:author | pubmed-author:SatouHH | lld:pubmed |
| pubmed-article:7627722 | pubmed:author | pubmed-author:OgoshiKK | lld:pubmed |
| pubmed-article:7627722 | pubmed:author | pubmed-author:MitomiTT | lld:pubmed |
| pubmed-article:7627722 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7627722 | pubmed:volume | 13 | lld:pubmed |
| pubmed-article:7627722 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7627722 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7627722 | pubmed:pagination | 363-9 | lld:pubmed |
| pubmed-article:7627722 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:meshHeading | pubmed-meshheading:7627722-... | lld:pubmed |
| pubmed-article:7627722 | pubmed:year | 1995 | lld:pubmed |
| pubmed-article:7627722 | pubmed:articleTitle | Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study. The Cooperative Study Group for Esophageal Cancer in Japan. | lld:pubmed |
| pubmed-article:7627722 | pubmed:affiliation | Department of Surgery II, Tokai University, Kanagawa, Japan. | lld:pubmed |
| pubmed-article:7627722 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7627722 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7627722 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7627722 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7627722 | lld:pubmed |
